Cat. No. 3260
Alternative Name: 4'-Epidoxorubicin
Chemical Name: (8S,10S)-10-[(3-Amino-2,3,6-trideox
Biological ActivityAntibiotic antitumor agent. Inhibits the synthesis and function of DNA (IC50 = 62.7 μM in rat glioblastoma cell lines) and inhibits the relaxing property of topoisomerase II.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Safety Data Sheet
Schott and Robert (1989) Comparative activity of anthracycline 13-dihydrometabolites against rat glioblastoma cells in culture. Biochem.Pharmacol. 38 4069. PMID: 2597184.
Cersosimo et al (1986) Epirubicin: a review of pharmacology, clinical activity, and adverse effects of an adriamycin analogue. J.Clin.Oncol. 4 425. PMID: 3005521.
Spadari et al (1986) DNA polymerases and DNA topoisomerases as targets for the development of anticancer drugs. Anticancer Res. 6 935. PMID: 3026237.
If you know of a relevant reference for this product please let us know.
Citations are publications that use Tocris products. Selected citations for Epirubicin hydrochloride include:
Robinson et al (2013) RB1 status in triple negative breast cancer cells dictates response to radiation treatment and selective therapeutic drugs. PLoS One 8 e78641. PMID: 24265703.
Do you know of a great paper that uses Epirubicin hydrochloride from Tocris? If so please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: Epirubicin hydrochloride, supplier, inhibitors, inhibits, DNA, synthesis, function, topoisomerase, II, Isomerases, antibiotics, 4-Epidoxorubicin, chemotherapeutics, Tocris Bioscience, DNA, RNA and Protein Synthesis Inhibitor products
Find multiple products by catalog number
New Products in this Area
Mitochondrial protonophore uncouplerRS 1
High affinity RAD51 activator; also CRISPR enhancer6-Hydroxy-DL-DOPA
Allosteric inhibitor of RAD52; also APE1 inhibitor
October 30 - November 3, 2016
Boston, MA, USA